Arpeggio Biosciences, Inc. filed a Form D with the Securities and Exchange Commission on 2025-11-24.
Arpeggio Biosciences, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 24, 2025. The filing reports $20.04M sold. Its industry group is Other Technology. It names Joseph Azofeifa (Executive Officer, Director), Laura Norris (Executive Officer), Samuel Kintz (Director) (SEC Form D, November 24, 2025).
Is this your company?
Sell to companies like Arpeggio Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-11-24 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Arpeggio Biosciences, Inc.
Free to see. No signup.
More on the people and the money behind Arpeggio Biosciences, Inc., from the filings we hold.
Other Technology raises by companies based in Colorado, filed in November 2025, largest first.
Get an email when Arpeggio Biosciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Arpeggio Biosciences, Inc. raises, hires or launches. No email unless you switch it on.
Watch Arpeggio Biosciences, Inc. →Get the full cited report on Arpeggio Biosciences, Inc.
What the filing shows about Arpeggio Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Arpeggio Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Arpeggio Biosciences, Inc.'s address as 4888 Pearl East Circle, Suite 110E, Boulder, CO 80301.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Arpeggio Biosciences, Inc. See pricing
Arpeggio Biosciences, Inc. is a registered filer with the SEC (CIK 1786698) and has filed since 2025-03-27. 2 filings are on record, the latest on 2025-11-24.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Arpeggio Biosciences, Inc.'s Form D of 2025-11-24 names Joseph Azofeifa, Laura Norris, Samuel Kintz and 4 more as its officers, directors or promoters.
Its new offerings report $24.07M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 3844 filings in Other Technology, totalled by week. The dot is this raise, $20.04M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Joseph Azofeifa is named as Executive Officer and Director on the Form D that Arpeggio Biosciences, Inc. filed with the SEC on 24 November 2025, one of 7 people that filing names.
Laura Norris is named as Executive Officer on the Form D that Arpeggio Biosciences, Inc. filed with the SEC on 24 November 2025, one of 7 people that filing names.
Samuel Kintz is named as Director on the Form D that Arpeggio Biosciences, Inc. filed with the SEC on 24 November 2025, one of 7 people that filing names.
David Allison is named as Director on the Form D that Arpeggio Biosciences, Inc. filed with the SEC on 24 November 2025, one of 7 people that filing names.
Mira Chaurushiya is named as Director on the Form D that Arpeggio Biosciences, Inc. filed with the SEC on 24 November 2025, one of 7 people that filing names.
Aaron Royston is named as Director on the Form D that Arpeggio Biosciences, Inc. filed with the SEC on 24 November 2025, one of 7 people that filing names.
Timothy Read is named as Executive Officer on the Form D that Arpeggio Biosciences, Inc. filed with the SEC on 24 November 2025, one of 7 people that filing names.
7 people named on the filing — 3 holding an executive role and 4 as directors only.
Named as of the 2025-11-24 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Arpeggio Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Arpeggio Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Arpeggio Biosciences, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Arpeggio Biosciences, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Arpeggio Biosciences, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Arpeggio Biosciences, Inc.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises in Denver and Boulder
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/arpeggio-biosciences-inc-form-d-25000001